<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: This study aimed to investigate the possible modification of the neuroprotective effect of <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="29749">ferulate</z:chebi>, when orally co-administered with <z:chebi fb="0" ids="28093">borneol</z:chebi>, in transient global <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>-induced functional, histological and cellular alterations in mice </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> was conducted in C57 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/6J mice for 25 min </plain></SENT>
<SENT sid="2" pm="."><plain>The mice were then subjected to a water maze test over an extended recovery period, followed by an assessment of <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> in the CA1 region of the hippocampus (<z:chebi fb="1" ids="51686">haematoxylin</z:chebi> and eosin staining) </plain></SENT>
<SENT sid="3" pm="."><plain>The blood-brain barrier permeability (Evans blue tracing), <z:hpo ids='HP_0002181'>brain oedema</z:hpo> and <z:mp ids='MP_0003674'>oxidative stress</z:mp> were assayed and histological sections were also immunostained for gliofibrillar acid protein (GFAP) expression </plain></SENT>
<SENT sid="4" pm="."><plain>KEY FINDINGS: The <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> reperfused mice were associated with long-lasting spatial learning deficits in the absence of other behavioural impairments and with <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> in the hippocampal CA1 region </plain></SENT>
<SENT sid="5" pm="."><plain>However, the histological injuries were significantly attenuated by oral co-administration of <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="29749">ferulate</z:chebi> and <z:chebi fb="0" ids="28093">borneol</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, combined treatment with <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="29749">ferulate</z:chebi> and <z:chebi fb="0" ids="28093">borneol</z:chebi> resulted in a significant reduction in <z:hpo ids='HP_0002181'>brain oedema</z:hpo>, GFAP-positive cells, malonaldialdehyde levels and blood-brain barrier permeability, but an increase in <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase activity </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="28093">Borneol</z:chebi> may have benefits for the neuroprotective effect of <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="29749">ferulate</z:chebi> against injury induced in the brain by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>/reperfusion </plain></SENT>
</text></document>